5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.86▲ | 9.81▲ | 9.80▲ | 10.38▼ | 10.79▼ |
MA10 | 9.81▲ | 9.86▲ | 9.96▼ | 10.88▼ | 11.31▼ |
MA20 | 9.83▲ | 10.07▼ | 10.11▼ | 11.07▼ | 10.68▼ |
MA50 | 10.10▼ | 10.43▼ | 10.77▼ | 11.46▼ | 11.43▼ |
MA100 | 10.29▼ | 10.94▼ | 11.07▼ | 10.64▼ | 12.48▼ |
MA200 | 10.79▼ | 11.17▼ | 11.45▼ | 11.06▼ | 12.73▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.031▲ | 0.004▲ | 0.001▲ | -0.150▼ | -0.011▼ |
RSI | 50.284▲ | 40.317▼ | 37.374▼ | 33.679▼ | 42.017▼ |
STOCH | 96.065▲ | 23.199 | 11.831▼ | 11.208▼ | 33.724 |
WILL %R | 0.000▲ | -57.447 | -72.222 | -90.323▼ | -75.682▼ |
CCI | 184.975▲ | -21.343 | -56.730 | -143.124▼ | -140.174▼ |
Tuesday, September 30, 2025 03:13 AM
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an ...
|
Thursday, September 18, 2025 03:26 AM
The Company's application to European regulators has been formally approved, adding Ireland as an approved country in FLAMINGO-01 in addition to Spain, France, Germany, Italy, Poland, Romania, and the ...
|
Tuesday, September 16, 2025 07:37 AM
Discover GLSI's HER2+ breast cancer vaccine progress, FDA Fast Track benefits, and key financial risks. Click here to read my most recent analysis of GLSI.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 10.04 | 10.57 | 9.725 | 9.95 | 50,300 |
29/09/25 | 10.38 | 10.445 | 10.015 | 10.16 | 75,500 |
26/09/25 | 10.35 | 10.489 | 9.76 | 10.40 | 104,200 |
25/09/25 | 10.95 | 10.99 | 10.31 | 10.42 | 107,400 |
24/09/25 | 11.04 | 11.40 | 10.90 | 10.945 | 113,000 |
23/09/25 | 11.79 | 11.99 | 10.98 | 10.98 | 126,300 |
22/09/25 | 11.44 | 11.84 | 11.35 | 11.80 | 57,200 |
19/09/25 | 11.59 | 11.66 | 11.20 | 11.46 | 104,600 |
18/09/25 | 11.43 | 11.60 | 11.20 | 11.54 | 65,000 |
17/09/25 | 11.22 | 11.66 | 11.032 | 11.15 | 75,700 |
|
|
||||
|
|
||||
|
|